Sort
326,823 grants matching “clinical trial”
Growth Factor Imaging and Photoimmunotherapy
$2,426,730Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Development and identification of magnetic resonance, electrophysiological, and fiber-optic imaging biomarkers of myofascial pain
$2,426,607Song Hu · Washington University · R33 · FY2025 · AT
IMmunoPhenotyping Assessment in a COVID-19 Cohort (IMPACC): Clinical and Data Coordinating Center (CDCC)
$2,426,447Ofer Levy · Boston Children'S Hospital · U19 · FY2020 · AI
Clinical and Data Coordinating Center (CDCC)]
$2,426,447Ofer Levy · Boston Children'S Hospital · U19 · FY2020 · AI
Targeting Inflammation and Alloimmunity in Heart Transplant Recipients with Tocilizumab
$2,426,322Joren C Madsen · Massachusetts General Hospital · U01 · FY2023 · AI
Tissue destruction and healing in Celiac Disease
$2,426,298Bana Jabri · University Of Chicago · RC2 · FY2022 · DK
Longitudinal Imaging Biomarkers of Prodromal DLB
$2,425,965Kejal Kantarci · Mayo Clinic Rochester · U01 · FY2022 · NS
Columbia Collaborative HIV/AIDS Clinical Trials Unit
$2,425,739Scott M Hammer · Columbia University Health Sciences · UM1 · FY2013 · AI
Disparities in REsults of Immune Checkpoint Inhibitor Treatment (DiRECT): A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 in a Community Oncology Setting
$2,425,687Song Yao · Roswell Park Cancer Institute Corp · UH3 · FY2025 · CA
Adolescent Trials Network for HIV/AIDS Intervention
$2,425,648Westat, Inc. · U01 · FY2003 · HD
Alzheimer's Disease Research Center at Columbia University
$2,425,493Michael Shelanski · Columbia University Health Sciences · P50 · FY2012 · AG
Calcium Signaling &Prefrontal Deficits in Schizophrenia
$2,425,320Yale University · P50 · FY2004 · MH
NCI Community Oncology Research Program 2025 Extension Request
$2,425,145William J Irvin · Southeast Clinical Oncol Res Consortium · UG1 · FY2025 · CA
Optimization of Iron Chelator Delivery System
$2,425,024Judith K Gwathmey · Gwathmey, Inc. · R44 · FY2008 · HL
Effects of reprogrammed and engineered MSCs on diabetic complications
$2,424,957Young-Sup Yoon · Emory University · DP3 · FY2015 · DK
Data Infrastructure and Molecular Atlas for Alzheimer's Disease: Connecting Exposome, Gut Microbiome, and Metabolome.
$2,424,945Rima F Kaddurah-Daouk · Duke University · U19 · FY2022 · AG
The Ohio Valley Node of the Clinical Trials Network
$2,424,851T John Winhusen · University Of Cincinnati · UG1 · FY2020 · DA
Di-Leu-enabled multiplexed quantitation for biomarker discovery and validation in Alzheimer's disease
$2,424,837Lingjun Li · University Of Wisconsin-Madison · RF1 · FY2018 · AG
Breast and Other Cancers in the California Teachers Cohort
$2,424,791Leslie Bernstein · Beckman Research Institute/City Of Hope · R01 · FY2014 · CA
Washington University PDX Development and Trial Center
$2,424,750Ramaswamy Govindan · Washington University · U54 · FY2017 · CA
Dietary and Hormonal Determinants of Cancer in Women
$2,424,605Meir J Stampfer · Brigham And Women'S Hospital · P01 · FY2017 · CA
ACO/Public Health Collaborative Preventive Care Delivery to Priority Populations
$2,424,597Allison Kempe · University Of Colorado Denver · R18 · FY2013 · HS
Synthetic DNA-launched and adjuvanted Env immunogens for HIV
$2,424,072David B. Weiner · Wistar Institute · U19 · FY2025 · AI
Bronchiectasis and chronic airway infection
$2,423,956Kevin Fennelly · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL
New Approaches to Inducing Cardiac Allograft Tolerance
$2,423,933Joren C Madsen · Massachusetts General Hospital · P01 · FY2025 · HL